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Department of Dietetics and Nutrition, Florida International University, USA
Abstract
Background: Omega-3 fatty acids (n-3) may be protective of cardiovascular risk factors for vulnerable 
populations. The purpose of this study was to assess the association between n-3 with, C-reactive protein (CRP), 
and homocysteine (HCY) in Black minorities with and without type 2 diabetes. 
Methods: A cross-sectional study was conducted with 406 participants: Haitian Americans (HA): n=238. African 
Americans (AA): n=172. Participants were recruited from a randomly generated mailing lists, local diabetes educators, 
community health practitioners and advertisements from 2008-2010. Sociodemographics and anthropometrics were 
collected and used to adjust analyses. All dietary variables were collected using the semi-quantitative food frequency 
questionnaire (FFQ) and used to quantify vitamin components. Blood was collected to measure CVD risk factors 
(blood lipids, HCY, and CRP). 
Results: African Americans had higher waist circumferences and C-reactive protein and consumed more 
calories as compared to Haitian Americans. Omega 3 fatty acid intake per calorie did not differ between these 
ethnicities, yet African Americans with low n-3 intake were three times more likely to have high C-reactive protein as 
compared to their counterparts [OR=3. 32 (1. 11, 9. 26) p=0.031]. 
Although homocysteine did not differ by ethnicity, African Americans with low omega 3 intake (<1 g/day) were four 
times as likely to have high homocysteine (>12 mg/L) as compared to their counterparts, adjusting for confounders 
[OR=4.63 (1.59, 12.0) p=0.004]. Consumption of n-3 by diabetes status was not associated with C-reactive protein 
or homocysteine levels. 
Conclusions: Consumption of n-3 may be protective of cardiovascular risk factors such as C-reactive protein 
and homocysteine for certain ethnicities. Prospective studies are needed to confirm these results.
Keywords: n-3 fatty acids; Homocysteine; C-reactive protein; 
African Americans; Haitian Americans; Type 2 diabetes
Introduction
Cardiovascular disease (CVD) is one of the most prevalent causes 
of morbidity and mortality worldwide [1]. Since it is possible to have 
normal blood lipids and be at risk for CVD, other blood markers such 
as C-reactive protein (CRP) [2-3] and homocysteine (HCY) [4] have 
been considered independent risk factors for CVD. It has been well-
established that CVD involves systematic inflammation [5]. Prospective 
studies and primary prevention trials have demonstrated that CRP, an 
acute phase protein and marker of chronic, low-level inflammation, 
predicts CVD risk as well as CVD in those without prior disease [6]. 
High blood levels of HCY are thought to play a role in endothelial 
damage through oxidative stress-based on molecular studies and 
have been established as a risk factor for CVD by retrospective and 
prospective studies [4]. 
Omega-3 fatty acids (n-3) have been associated with antioxidant 
properties related to the reduction of CVD risk in observational and 
randomized control trials [7]. In addition to their antioxidant properties, 
n-3 may be associated with reducing systemic inflammation. N-3, a type 
of polyunsaturated fat derived from either fish (as eicosapentaenoic 
acid (EPA) or docosahexaenoic acid (DHA) or plant sources, 
α-linolenic acid (ALA) have been shown to have a protective effect 
on cardiovascular disease (CVD) risk in numerous epidemiological 
studies [8-11]. Whether this effect is due to their antioxidant or anti-
inflammatory capacity, it has not been clearly established. 
Participants with diabetes are under increased oxidative stress due 
to factors such as: auto-oxidation of glucose which produces more 
free radical formation, imbalances in cellular oxidation and reduction, 
and decreased antioxidant defense systems [12]. Atherosclerosis and 
atherothrombosis processes are up-regulated in persons with diabetes 
[13]. Individuals with diabetes have more than double the risk for CVD 
as compared to their counterparts [14]. 90-95% of the cases of diabetes 
type 2 incidences (T2D), has been attributed to genetic predisposition 
and lifestyle factors such as diet, physical activity, alcohol, obesity, and 
smoking [14]. 
Blacks are among those at high risk for and a higher prevalence of 
diabetes (11.8%) which places them at greater risk for CVD [14]. There 
is limited research on T2D and CVD risk factors in Haitian Americans 
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(HA) and African Americans (AA). The majority of the existing data 
groups Blacks together; hence, there are no clear distinctions and 
acknowledgement of the widespread differences in culture, foods, and 
lifestyle among Black subgroups. In addition, there is no research, to 
date, on the association between n-3 with CVD risk factors specific to 
Black populations with T2D. It is possible that ethnicity may modify 
the effect of n-3 on either or both HCY and CRP. Therefore, this study 
investigated the association of n-3 with biomarkers of CVD risk: 
HCY and CRP, in HA and AA with and without T2D. The following 
hypotheses were tested: Participants with low n-3 intake, regardless of 
ethnicity and diabetes status, will be more likely to have: 1) high CRP, 
and 2) high HCY. The establishment of cut-off points for n-3, CRP, and 
HCY were based on clinical significance and the sample medians, as 
explained in the Statistical analysis section. 
Methods
Study participants
This was a cross-sectional study of AA and HA with and without 
T2D. AA was recruited from Miami-Dade and Broward counties 
in Florida, USA using mailing lists purchased from Knowledge Base 
Marketing, Inc. The subjects were randomly selected by alternating 
between subjects with and then without T2D. For AA, 7,550 letters were 
mailed to potential participants with and without T2D, four percent 
responded (n=256), and 6.3% (n=477) were returned due to unknown 
addresses. HA participants (n=259) were recruited differently because 
mailing lists were not available for this group. Recruitment was done 
in the community through local diabetes educators and community 
health practitioners in Miami-Dade and Broward Counties, who 
were either former students or in close contact with the Department 
of Dietetics and Nutrition at Florida International University (FIU). 
Also, FIU faculty, staff and students, as well as, several residential 
rental facilities received invitational flyers and were requested to assist 
with the recruitment process. Advertisements were circulated in local 
Haitian newspapers, churches, supermarkets, restaurants, and also 
aired on local Creole stations. Interested participants were interviewed 
on the phone to obtain age, gender, and T2D status. Exclusion criteria 
consisted of those being younger than 35 years old, other ethnicity, 
severe diabetes complication (blindness, amputations, kidney failure) 
and having other major chronic diseases or illnesses, specifically, liver 
disease, congestive heart failure, bariatric surgery, cancer, AIDS/HIV. 
Eligible subjects were requested to come to the Human Nutrition 
Laboratory at FIU for blood collection after an eight-hour overnight 
fast; participants were asked to refrain from smoking and engaging 
in any unusual exercise prior to this visit. The study was approved by 
the Institutional Review Board at FIU. Written consent in English or 
Creole was required from all participants; and, all participants signed 
an informed consent form prior to enrollment in the study. 
Data collection
Participants completed a socio-demographic questionnaire, which 
included: age, gender, duration of residence in the USA, language 
preference, education, income, employment status, medications, and 
family history of T2D and CHD. Weight, height, waist circumference 
and blood pressure were performed in the Human Nutrition Laboratory 
of the Principal Investigator. Body mass index (es) (BMI) was calculated 
as weight in kg/height in m2. 
Blood sampling: A certified phlebotomists collected a 20 ml sample 
of venous blood from each subject after an 8-hour overnight fast. A 
vacationer Serum Separator Tube (SST) was used for the lipid profile 
sample. After complete coagulation (i.e., 30-45 minutes), the SST was 
centrifuged at 2500 rpm for 30 minutes. One sample of the serum was 
used for lipid profile analysis and the other was frozen at -70°C for HCY 
and high-sensitivity C-reactive protein (hs-CRP) analysis. Laboratory 
results showed that 13 participants (HA=8; AA=4) who reported 
not having diabetes were reclassified as having T2D according to the 
American Diabetes Association Standards. These participants were 
referred to their physicians and were included in the group with T2D. 
Biochemical analysis: Plasma total cholesterol (TC), triglycerides 
(TG), low-density lipoprotein cholesterol (LDL-C), and high-density 
lipoprotein cholesterol (HDL-C) were assayed by enzymatic methods 
(Cobas Mira, Roche Diagnostics, Indianapolis, IN). LDL-C was 
estimated by the Friedewald formula: {LDL-Cl=TC (mmol/L)-HDL-C 
(mmol/L)-TG (mmol/L) 2.2 (mmol/L)}. Hs-CRP was analyzed by 
Immulite (Diagnostic Products Corporation, Los Angeles, CA). The 
combined free and protein-bound plasma HCY was measured using 
the IMx System based on the Fluorescence Polarization Immunoassay 
technology (Axis-Sheild ASA, Oslo, Norway; Abbot Diagnostic 
Division, Abbott Laboratories, Abbott Park, IL). 
Nutritional variables: All dietary variables were collected using 
the semi-quantitative food frequency questionnaire (FFQ) developed 
by Walter C. Willett. This FFQ has been extensively validated and 
standardized in several multiethnic population-based prospective and 
cross-sectional studies and for determination of chronic diseases such 
as CVD and T2D [15,16]. Participants reported their consumption of 
various foods over the past year. This FFQ describes individuals’ intake 
of macro- and micronutrients, dietary patterns, food habits, changes of 
consumption in last 10 years, frequency of foods, usual serving size, and 
servings per week of food items that are not listed. The FFQ has several 
advantages: it is self-administered, inexpensive, subject burden is 
minimal, and does not require specialized training for the participant. 
Statistical analysis: Prior to analysis, all continuous variables were 
tested by Q-Q plots and when needed were log-transformed to achieve 
linearity. Total n-3 intake (from ALA, DHA, and EPA in food and 
supplements) was transformed into a binary variable for adequate versus 
inadequate intake in grams/day. Since no definitive recommendations 
are given for n-3 cut-offs were considered as adequate for either 1 g or 
2 g per day based on model fit. Participants were excluded if they met 
one or more of the following conditions: 1) missing values n-3, HCY, or 
hs-CRP; 2) CRP higher than 10 mg/L (n=95) since this elevation might 
be a result of an acute infection and cannot be used to asses CVD risk 
[17]; and 3) total energy intake <500 or >5000 kcal/day. A total of 490 
participants (HA=238; AA=172) with and without type 2 diabetes were 
included in the final data analysis. Logistic regression models were used 
to assess the odds ratios for n-3 intake. One and two-way interactions 
were tested for ethnicity and diabetes status with n-3. Analysis was 
conducted for each ethnicity, based on the significance of the two-
way interactions. Adjustment variables for final models included: age, 
gender, smoking status, waist circumference, and Kcal/day. Covariates 
vitamin B, saturated fat, fiber, and physical activity were tested along 
with the adjustment variables and not retained. A binary variables were 
created for HCY, where the 75th percentile and above was considered 
high (12 mg/L) and for CRP, where high CRP was considered ≥ 3 mg/
dL. Data were analyzed using the statistical software IBM SPSS Statistics 
version 19 (SPSS Inc, Chicago, IL) and statistical significance was set at 
p<0. 05. 
Results
General characteristics of the study population by ethnicity are 
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presented in table 1. There was no difference in the gender distribution 
between AA and HA (p=0.327); albeit, AA were approximately 3 years 
younger than HA. African Americans consumed more calories and 
higher grams of n-3; however, n-3 per kilocalorie was not statistically 
different between them (AA=0.859×10-4; HA=0.847×10-4). African 
Americans had higher waist circumferences (p<0.001) and CRP 
(p<0.001) as compared to HA; but there was no statistical difference 
between ethnicities in HCY levels (p=0.714). 
Table 2 depicts the logistic regression model for the odds of having 
high CRP (≥ 3 mg/L) by n-3 consumption, ethnicity and diabetes status. 
Low n-3 intake (<2 g/day) was not an independent predictor of CRP as 
hypothesized. Instead, ethnicity by n-3 intake was significant. African 
Americans with low n-3 intake were more likely to have high CRP as 
compared to their counterparts [OR=3.21 (1.11, 9.26) p=0.032]. This 
relationship was not significant for HA (data not shown). Although 
having diabetes was associated with high CRP, as expected, diabetes 
status by n-3 intake was not a significant predictor of high CRP 
(p=0.132). 
The logistic regression model for the odds of high HCY (>12 
mg/L) by n-3 intake, ethnicity and diabetes status is presented in table 
3. African Americans with low n-3 intake (<1 g/d) were more than 
four times likely to have high HCY as compared to their counterparts 
[OR=4.36 (1.59, 12.0) p=0.004]. Again, this relationship was not 
significant for Haitian Americans (data not shown). Diabetes status and 
diabetes by n-3 intake were not associated with HCY in this model. A 
comparison of means was conducted for each ethnicity for HCY levels 
and there were no differences by diabetes status for AA (p=0.235) and 
for HA (p=0.412) (data not shown). 
Discussion
This study investigated n-3 and its association with lipid profiles, 
CRP and HCY in AA, and HA with and without T2D. Ethnicity modified 
the relationship between omega 3 intake and the cardiovascular risk 
markers, CRP and HCY. Most studies for n-3 intake with either CRP or 
HCY are performed in specific populations, but do not compare across 
ethnicities and diabetes status. Moreover, the association among n-3 
and CRP levels in cross sectional studies and the effects of omega-3 
supplementation/fish intake on serum CRP levels have inconsistent 
findings. Similarly, n-3 interventions have produced inconclusive 
results for HCY due to small sample sizes and short duration of 
supplementation. 
Effect of omega 3 on CRP
Contradictory findings have been found for Caucasian populations. 
Several intervention studies have shown improvements in CRP 
corresponding to n-3 consumption among Caucasian populations [18-
20]. On the other hand, no improvements in CRP were found after a 
placebo-control intervention with n-3 in a small sample of healthy, 
middle-aged, Caucasian adults [21]. Conversely, an inverse relationship 
between n-3 intake and CRP level was found for a large sample of 
Caucasian men, aged 42-60 years [22]. A cross-sectional study of 
healthy Australian adults showed an inverse association of CRP with n-3 
intake [23]. N-3 levels assessed in blood were inversely associated with 
CRP in a group of healthy adults [24]. Tumor necrosis factor (TNF-α), 
another indicator of inflammation, but not CRP, was lowered after n-3 
supplementation (2.4 g/day) for a small group of hemodialysis patients 
[25]. C-reactive protein levels reduced after a 12-week intervention 
for the group given n-3 and statins as compared to the control given 
statins only in patients with dyslipidemia [26,27]. N-3 consumption in 
the form of non-fried fish was associated with lower CRP levels in a 
cross-section study of the multi-ethnic study of atherosclerosis (MESA) 
cohort [28]. 
The metabolic role of n-3 as a supplement for individuals with 
type 2 diabetes has a matter of debate due to a potential for increase 
in hemoglobin A1c, fasting blood glucose, and lipid peroxidation 
[28,29]. Shidfar et al. [29] found no effects on glycemic control or 
lipoproteins with a supplementation of 2 g per day of n-3 and attribute 
Variable African American
Haitian 
American P-value
Categorical variables N (% within ethnicity) 
Gender (males) 93 (54.1) 115 (49.1) 0.327
Low n-3<1 g/day 43 (25.0) 97 (41.5) 0.001
High HCY
(>12 mg/L) 45 (26.2) 54 (23.1) 0.474
High CRP (≥ 3 mg/L) 76 (44.2) 64 (27.4) 0.001
Current smoker 62 (36.0) 15 (6.4) <0.001
Continuous variables (mean ± SD)
Age (years) 53.3 ± 9.5 56.0 ± 11 0.008
Waist circumference (cm) 106.7 ± 17 97.9 ± 12 <0.001
Homocysteine (mg/L) 10.3 ± 4.0 10.2 ± 3.8 0.714
CRP (mg/L) 3.15 ± 2.5 2.21 ± 2.0 <0.001
N-3 (grams) 1.89 ± 1.3 1.49 ± 1.1 0.001
ln Kcal 7.57 ± .51 7.34 ± .51 <0.001
Kcal 2199 ± 1043 1759 ± 942 <0.001
Abbreviations:  HCY=homocysteine; CRP=high-sensitivity C=reactive protein; 
n-3=omega-3 fatty acids.
Table 1: General characteristic by ethnicity.
Variable
OR
95% C.I. for OR p value
Lower Upper
African American 0.57 0.22 1.49 0.249
Haitian American (reference) 1.00 1.00 1.00 -
African American by low omega-3 fatty 
acids
3.21 1.11 9.26 0.031
low omega-3 fatty acids<2 g/day 1.38 0.541 3.51 0.502
With type 2 diabetes 2.72 1.08 6.82 0.033
With diabetes by low omega 3 0.44 0.155 1.28 0.132
Model Summary: χ2(10)=67.1 N=406 p<0.001
Nagelkerke R2=0.210. 
The model classified 74% of the cases of CRP, correctly.
Model adjusted by kcal (p=0.307), waist circumference (p<0.001), gender 
(p=0.262), smoking (p=0.587), and age (p=0.510).
Table 2: Odds ratio of high C-reactive protein (CRP) (≥ 3 mg/L) by omega-3 fatty 
acid intake, ethnicity and diabetes status.
OR
95% C.I. for OR
Variable Lower Upper p value
AA by low omega-3 fatty acids
(≤ 1 g/day) 4.36 1.59 12.0 0.004
African American 0.61 0.31 1.20 0.155
Haitian American (reference) 1.00 - - -
Diabetes by low omega-3 fatty acids 1.02 0.36 2.90 0.965
Diabetes 1.10 0.59 2.03 0.770
Low omega-3 fatty acids (≤ 1g/day) 0.75 0.58 2.02 0.576
Model Summary: χ2 (10) (N=406)=30.9; p=0.001.
Nagelkerke R2=0.109. The model classified 75% of the cases of HCY, correctly.
The model was adjusted by age (p=0.001), gender (p=0.305), waist circumference 
(p=0.225), smoking (p=0.029), and calories (p=0.765).
Table 3: Odds ratio of high homocysteine (HCY) (>12 mg/L) by omega-3 fatty acid 
intake, ethnicity and diabetes status.
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disparate findings to differences in diabetes medications, the presence 
of insulin resistance, hypertension, and obesity. Evidence for the 
reduction of CRP by n-3 in populations with type 2 diabetes has not 
been established. Several intervention studies showed no effect of n-3 
supplementation on CRP for populations with type 2 diabetes [28,30]. 
C-reactive protein levels were not affected by n-3 supplementation (3 
g/day for eight weeks) in a randomized control trial for persons with 
type 2 diabetes; yet IL-2 and TNF-α, other indicators of inflammation, 
were reduced in the n-3 group [30]. No significant changes in CRP were 
found after two-month supplementation with n-3 for individuals with 
type 2 diabetes; however, HCY levels were significantly reduced [28]. A 
meta-analysis of n-3 and its effect on inflammatory factors from earlier 
studies found only two trials evaluating CRP on individuals with type 2 
diabetes [31]. N-3 did not significantly lower CRP for either trial [31]. 
However, n-3 in blood was inversely associated with CRP in obese and 
non-obese, otherwise healthy, Greek adults [32]. These studies suggest 
that low-grade, systemic inflammation, measured by CRP, is a chronic 
disease indicative of life-long diet and may not be responsive to short-
term intervention. 
Effect of n-3 with HCY
Supplementation with n-3 was associated with a decrease in 
HCY according to a meta-analysis of 11 intervention trials [33]. N-3 
supplementation was associated with the reduction of HCY for healthy 
individuals [18], women [34], and for adults with type 2 diabetes and 
dyslipidemia [35]. Several n-3 supplementation trial aimed to lower 
HCY contained other treatments such as statins, fiber, or antioxidant-
rich juices. Reduction in HCY after 12-weeks with n-3 supplementation 
(3.6 g/day) for otherwise healthy individuals with elevated HCY also 
included statins, multivitamins and fiber; however, there was no 
reduction in HCY in the placebo group (statins, only) [18]. Tomato 
juice enriched with n-3 (250 mg EPA+DHA) significantly reduced 
HCY (approximately 3 μM), after 2-weeks, as compared to tomato 
juice without n-3 for a small sample of healthy women; however, by the 
authors’ own admission, both juices provided antioxidant compounds 
such as phenolics and lycopene [34]. 
Similarly, cross-sectional studies have shown high n-3 intake 
associated with low HCY for patients with type 2 diabetes [28], healthy 
males [36] and older Chinese adults [37]. The protective effect of n-3 
may be attributed, in part, to its role in activating other antioxidants. 
In fact, n-3 has been associated with increased activity of glutathione 
peroxidase, an antioxidant enzyme with selenium acting as a cofactor, 
in a population with type 2 diabetes [38]. 
Confounders of n-3 with CRP and HCY: metabolic state, 
ethnicity, genetics
It has not been determined whether ethnic differences in the 
relationships between either CRP or HCY can be attributed to 
metabolic, cultural, or genetic factors. With respect to metabolic 
differences, there is an increasing number of individuals, particularly 
non-Caucasian ancestry, that are of a presumable ‘normal body weight’, 
but have a phenotype that can be referred to ‘metabolically obese’ [39]. 
Increased susceptibility to CVD and diabetes may be due, in part, 
to high free-radical level in plasma which impairs insulin function 
[40]. The association of omega 3 intake with HCY and CRP for AA 
in the present study may be due, in part, to their susceptibility to 
cardiovascular disease; however, prospective studies are needed to 
make any determinations. Another possible confounder is type of n-3 
(EPA/DHA versus ALA) and its interaction with metabolic factors. 
Metabolic effect differences were found between fish (a source of EPA/
DHA) and flaxseed oil (a source of ALA) on glucose homeostasis, 
but not on CRP or lipid metabolism in a primarily Caucasian cohort 
of women with polycystic ovary syndrome [41]. Although there were 
several ethnicities in this 6-week prospective randomized controlled 
study, their numbers were insufficient to access ethnic influence on 
the effect of n-3 on metabolic outcomes [41]. For Caucasian patients 
with end-stage renal disease, serum DHA, but not EPA was inversely 
associated with plasma HCY [42]. The higher degree of unsaturation in 
DHA (22:6) as compared to EPA (22:5) may be a factor in hemodynamic 
and anti-atherogenic properties that affect HCY metabolism as well as 
the metabolic state of the target population [43]. A major cultural factor 
of ethnic differences, food preparation, may change the effectiveness of 
n-3; in particular, deep frying [44]. Ethnic difference in cooking may 
have influenced the relationship between n-3 with HCY and CRP. Food 
preparation may differ by ethnicity for our participants since AA were 
born in the US; whereas HA were all born in Haiti. Vast differences in 
diet were reported between AA and HA [45]. Finally, genetic differences 
among ethnicities may be a factor influencing the association of n-3 
with HCY and CRP; however, there are no studies, to date, that have 
investigated this area. Since n-3 has been shown to regulate gene 
expression for antioxidant as well as reactive oxidative species, it is 
plausible that the genetic differences between AA and HA may explain 
differences in the effectiveness of n-3 in metabolic functions. The extent 
to which the multifaceted aspects of ethnicity: metabolic, cultural, and 
genetic, modify the relationship between n-3 with HCY and CRP has 
not been established. 
Limitations
This study had several limitations. The results were cross-sectional 
and causality cannot be assumed. N-3 was assessed by a food frequency 
questionnaire and the actual blood levels may differ. Food preparation 
and self-report of dietary data may have bias the results. On the other 
hand, a food frequency questionnaire could represent a yearly average 
intake of n-3; whereas, blood levels of n-3 represent recent consumption. 
Although other antioxidants were not correlated with CRP and HCY, 
they were not considered in the final models and may have some 
confounding effect in the relationship between n-3 consumption and 
CRP and HCY levels. 
Conclusion
N-3 intake was significantly associated with CRP and HCY levels 
for AA but not for HA. Diabetes status and consumption of n-3 
did not significantly predict odds of high CRP or high HCY. These 
findings suggest the need for prospective and intervention studies of 
measurement of n-3 in blood levels and cardiovascular events follow-
up between and across multiethnic populations with and without type 
2 diabetes. 
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